These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11196122)

  • 1. A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms.
    Oruç S; Sener EC
    Int Ophthalmol; 1999; 23(2):69-73. PubMed ID: 11196122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of topical apraclonidine on flow properties of central retinal and ophthalmic arteries.
    Celiker UO; Celebi S; Celiker H; Celebi H
    Acta Ophthalmol Scand; 1996 Apr; 74(2):151-4. PubMed ID: 8739680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels.
    Nicolela MT; Buckley AR; Walman BE; Drance SM
    Am J Ophthalmol; 1996 Dec; 122(6):784-9. PubMed ID: 8956632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL; Nau C; Brubaker RF
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma.
    Avunduk AM; Sari A; Akyol N; Oztürk O; Kapicioglu Z; Erdöl H; Imamoglu HI
    Ophthalmologica; 2001; 215(5):361-5. PubMed ID: 11528262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to blood flow in the rabbit ophthalmic artery after topical treatment with timolol.
    Liu JH; Li R; Nelson TR; Weinreb RN
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):103-9. PubMed ID: 17444797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Simsek S; Ertürk H; Demirok A; Cinal A; Yasar T; Karadenizli C
    Eur J Ophthalmol; 1998; 8(3):167-72. PubMed ID: 9793771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.
    Stewart WC; Laibovitz R; Horwitz B; Stewart RH; Ritch R; Kottler M
    Arch Ophthalmol; 1996 Aug; 114(8):938-42. PubMed ID: 8694728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol.
    Sulewski ME; Robin AL; Cummings HL; Arkin LM
    Arch Ophthalmol; 1991 Jun; 109(6):807-9. PubMed ID: 1675049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different autoregulation response to dynamic exercise in ophthalmic and central retinal arteries: a color Doppler study in healthy subjects.
    Németh J; Knézy K; Tapasztó B; Kovács R; Harkányi Z
    Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):835-40. PubMed ID: 12397432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma.
    Uva MG; Longo A; Reibaldi M; Reibaldi A
    Am J Ophthalmol; 2006 Jun; 141(6):1158-60. PubMed ID: 16765700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 0.5% apraclonidine on optic nerve head and peripapillary retinal blood flow.
    Kim TW; Kim DM
    Br J Ophthalmol; 1997 Dec; 81(12):1070-2. PubMed ID: 9497467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timolol increased retrobulbar flow velocities in untreated glaucoma eyes but not in ocular hypertension.
    Bergstrand IC; Heijl A; Wollmer P; Hansen F; Harris A
    Acta Ophthalmol Scand; 2001 Oct; 79(5):455-61. PubMed ID: 11594978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate.
    Robin AL; Coleman AL
    Trans Am Ophthalmol Soc; 1990; 88():149-59; discussion 159-62. PubMed ID: 1982747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doppler ultrasonography of the central retinal artery in normals treated with topical timolol.
    Steigerwalt RD; Belcaro G; Cesarone MR; Laurora G; De Sanctis MT; Milazzo M
    Eye (Lond); 1993; 7 ( Pt 3)():403-6. PubMed ID: 8224295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Topically Applied 0.5% Apraclonidine Versus 0.5% Timolol Maleate on Intraocular Pressure of Healthy Horses.
    Ziadi A; Ozmaie S; Asghari A; Rajaei SM
    J Equine Vet Sci; 2022 Apr; 111():103886. PubMed ID: 35093487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of brimonidine tartrate on ocular hemodynamics in healthy volunteers.
    Jonescu-Cuypers CP; Harris A; Ishii Y; Kagemann L; Gazozi HJ; Rotenstreich Y; Chung HS; Martin B
    J Ocul Pharmacol Ther; 2001 Jun; 17(3):199-205. PubMed ID: 11436940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical timolol maleate on the ophthalmic artery blood pressure.
    Grunwald JE; Furubayashi C
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1095-100. PubMed ID: 2732023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.
    Stewart WC; Ritch R; Shin DH; Lehmann RP; Shrader CE; van Buskirk EM
    Arch Ophthalmol; 1995 Mar; 113(3):287-92. PubMed ID: 7887841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.